PIK3CA and neoplasm: With Alp as an additional chemotherapeutic agent, Cr@PD‐Alp exhibits superior potency toward the NSG mice bearing an MDA‐MB‐231 PIK3CA (H1047R/+) tumor and can inhibit tumor metastasis to the lungs.